FDA Inspection 1044390 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on Feb 13, 2018 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 13, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Orleans, LA (United States)